Charles Schwab Investment Management Inc. Has 8.67 Million Holdings in ZimVie Inc. - MarketBeat
ZIMV Stock | USD 13.64 0.15 1.11% |
Slightly above 51% of ZimVie's investor base is interested to short. The analysis of overall sentiment of trading ZimVie Inc stock suggests that many investors are impartial at this time. ZimVie's investing sentiment can be driven by a variety of factors including economic data, ZimVie's earnings reports, geopolitical events, and overall market trends.
ZimVie |
Charles Schwab Investment Management Inc. Has 8.67 Million Holdings in ZimVie Inc. MarketBeat
Read at news.google.com
ZimVie Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ZimVie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ZimVie Maximum Pain Price Across April 17th 2025 Option Contracts
ZimVie's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of ZimVie close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of ZimVie's options.
ZimVie Fundamental Analysis
We analyze ZimVie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ZimVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ZimVie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
ZimVie is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
ZimVie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ZimVie stock to make a market-neutral strategy. Peer analysis of ZimVie could also be used in its relative valuation, which is a method of valuing ZimVie by comparing valuation metrics with similar companies.
Peers
ZimVie Related Equities
SIBN | Si Bone | 18.29 | ||||
INGN | Inogen | 8.17 | ||||
CVRX | CVRx | 6.14 | ||||
LUNG | Pulmonx Corp | 4.29 | ||||
KIDS | Orthopediatrics Corp | 2.29 | ||||
OFIX | Orthofix Medical | 2.18 | ||||
NPCE | Neuropace | 1.42 | ||||
CNMD | CONMED | 0.99 | ||||
STE | STERIS Plc | 0.79 | ||||
SNN | Smith Nephew | 0.29 | ||||
BSX | Boston Scientific | 0.28 | ||||
SGHT | Sight Sciences | 0.31 | ||||
SYK | Stryker | 1.28 | ||||
AORT | Artivion | 1.81 | ||||
APYX | Apyx Medical | 6.29 | ||||
SRDX | SurModics | 6.76 |
Additional Tools for ZimVie Stock Analysis
When running ZimVie's price analysis, check to measure ZimVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZimVie is operating at the current time. Most of ZimVie's value examination focuses on studying past and present price action to predict the probability of ZimVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZimVie's price. Additionally, you may evaluate how the addition of ZimVie to your portfolios can decrease your overall portfolio volatility.